RecruitingNCT06762717

FARAPULSE™ Pulsed Field Ablation System

Real World Data Collection in Chinese Population Treated With the FARAPULSE™ Pulsed Field Ablation System

Sponsor

Boston Scientific Corporation

Enrollment

500 participants

Start Date

Oct 23, 2025

Study Type

OBSERVATIONAL

Conditions

Paroxysmal AF

Summary

To obtain real world data on the use of, and provide continued evidence on safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) system when used per hospitals' standard of care in Chinese population.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting real-world safety and performance data on the FARAPULSE Pulsed Field Ablation (PFA) system — a device used to treat heart rhythm problems by using electrical pulses to destroy abnormal heart tissue, instead of traditional heat or cold methods. **You may be eligible if...** - You are 18 or older - Your doctor has decided that cardiac ablation with the FARAPULSE system is the appropriate treatment for your heart condition - You are able to understand and sign the consent form - You are willing to participate in all required study visits **You may NOT be eligible if...** - You have a wall or patch between the upper chambers of your heart (interatrial baffle/patch) - You have a known or suspected heart tumor (atrial myxoma) - You had a heart attack in the last 14 days - You had a stroke or TIA in the last 30 days - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.